课题基金 / 基金详情

项目摘要

项目成果

David J. Garfinkel的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To observe aberrant target site preference by mutagenized elements, we constructed a S. cerevisiae strain in which the URA3 gene was placed in the genome upstream of a preferred glycyl-tRNA (suf16) on chromosome III. The configuration of this construction is such that correct targeting of an element upstream of the suf16 disrupts the URA3 thereby permitting survival of cells in the presence of FOA. Using repair-deficient Escherichia coli, we randomly mutagenized a plasmid containing the Ty1 element under the control of the GAL1 promoter, and containing the retrotransposition indicator, his3AI. Approximately 10,000 mutagenized plasmids were screened for transposition by survival on media lacking histidine, for aberrant targeting by failure to survive on media containing FOA, and absence of chromosomal duplications by the ability to survive on plates containing canavanine, the toxic analogue of arginine permease. Candidates from this initial screen were further analyzed by PCR of extracted genomic DNA for Ty1 insertions upstream of the suf 16. This screen generated 31 mutants of sufficient interest to warrant sequencing. Sequencing results showed mutations dispersed throughout the element, falling within the frameshift site, protease, the N-terminal zinc binding domain and active site domain of integrase. However, several mutations were found within the C-terminal domain of integrase, a region of no known function. Also, several mutations fell within the N-terminal region of reverse transcriptase. Although it may be counterintuitive to hypothesize that the targeting determinant resides in reverse transcriptase rather than integrase, a number of recent observations that reverse transcriptase and integrase remain functionally, if not physically, associated after proteolytic cleavage to form mature proteins, leads to speculation that the targeting determinant may be comprised of multiple sites. These mutant strains have now been relocated to the University of Georgia.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Effectors of retrotransposon movement
  • 批准号:
    9769817
  • 项目类别:
  • 资助金额:
    $44.01万
  • 财政年份:
    2018
  • 负责人:
    David J. Garfinkel
  • 依托单位:
Effectors of retrotransposon movement
  • 批准号:
    10224748
  • 项目类别:
  • 资助金额:
    $44.25万
  • 财政年份:
    2018
  • 负责人:
    David J. Garfinkel
  • 依托单位:
Antisense RNAs control retrotransposon copy number
  • 批准号:
    8325679
  • 项目类别:
  • 资助金额:
    $28.22万
  • 财政年份:
    2011
  • 负责人:
    David J. Garfinkel
  • 依托单位:
Antisense RNAs control retrotransposon copy number
  • 批准号:
    8686002
  • 项目类别:
  • 资助金额:
    $28.22万
  • 财政年份:
    2011
  • 负责人:
    David J. Garfinkel
  • 依托单位:
国内基金
海外基金
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    32170319
  • 项目类别:
    面上项目
  • 资助金额:
    58.00万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
  • 批准号:
    --
  • 项目类别:
    --
  • 资助金额:
    58万元
  • 批准年份:
    2021
  • 负责人:
    董春海
  • 依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
  • 批准号:
    31372080
  • 项目类别:
    面上项目
  • 资助金额:
    80.0万元
  • 批准年份:
    2013
  • 负责人:
    杨迎伍
  • 依托单位: